NEW YORK, NY / ACCESSWIRE / September 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Akcea Therapeutics, Inc. (NASDAQ:AKCA) to Ionis Pharmaceuticals, Inc. is fair to Akcea shareholders. Under the terms of the agreement, Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, for $18.15 per share in cash. On behalf of Akcea shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
If you are an Akcea shareholder and would like to discuss your legal rights and options, please visit Akcea Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
The investigation concerns whether Akcea and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to (1) obtain the best possible consideration for Akcea shareholders; (2) determine whether Ionis is underpaying for Akcea; and (3) disclose all material information necessary for Akcea shareholders to adequately assess and value the proposed transaction.
If you are an Akcea shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/akcea-therapeutics-inc-akca-stock-merger-ionis/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP